Insulin Protafan

Insulin Protafan: Medication of medium duration of action

Insulin Protafan is a drug belonging to the group of intermediate-acting insulins. It is produced by the companies Bryntsalov (Russia) and Novo Nordisk A/O (Denmark), and has the international name "Insulin-SrD". The drug is presented in the form of a suspension and solution for injection with a concentration of 40 IU/ml.

Insulin Protafan is an important medicine for patients suffering from diabetes. It has an intermediate duration of action, meaning that it provides stable blood glucose levels for a longer period of time compared to rapid-acting insulins.

The drug Insulin Protafan is widely used to control blood sugar levels in patients with type 1 and type 2 diabetes mellitus. It allows you to regulate the glycemic profile and prevent the occurrence of acute complications associated with insufficient insulin levels.

Synonyms for the drug Insulin Protafan include B-Insulin Berlin-Chemie, Berlinsulin N Basal U-40, Berlinsulin N Basal pen, Biogulin NPH U-100, Biogulin NPH U-40, Biogulin Lente U-40, Brinsulmidi MK, Brinsulmidi Ch, Brinsulmidi ChSP , B-Insulin SC Berlin-Chemie, Depot-Insulin S, Isofan Insulin, Isofan Insulin.

Insulin Protafan is produced in Russia and Denmark, which guarantees high quality and compliance with international standards. This drug is widely available and used in many countries to provide effective blood sugar control in patients with diabetes.

It is important to note that the use of Insulin Protafan should be carried out under the supervision of qualified medical personnel. The dosage and frequency of injections must be individualized according to the needs of each patient.

In conclusion, Insulin Protafan is a medium-acting medication that is widely used to control blood sugar levels in patients with diabetes. It provides a stable glycemic profile and helps prevent complications associated with insufficient insulin levelsInsulin Protafan: Features and Application

Insulin Protafan is a medium-acting drug that is used to control blood sugar levels in patients with diabetes. It is produced by Bryntsalov (Russia) and Novo Nordisk A/O (Denmark). This drug has the international name "Insulin-SrD" and is available in the form of an injection suspension and an injection solution with a concentration of 40 IU/ml.

Insulin Protafan belongs to the group of intermediate-acting insulins. It provides stable blood glucose levels for a longer time compared to fast-acting insulins. This allows patients with diabetes to effectively control their blood sugar levels and prevent the occurrence of acute complications.

The drug Insulin Protafan has several synonyms, including B-Insulin Berlin-Chemie, Berlinsulin N Basal U-40, Berlinsulin N Basal pen, Biogulin NPH U-100, Biogulin NPH U-40, Biogulin Lente U-40, Brinsulmidi MK, Brinsulmidi Ch , Brinsulmidi ChSP, V-Insulin SC Berlin-Chemie, Depo-Insulin S, Isofan Insulin, Isofan Insulin.

Insulin Protafan is produced in Russia and Denmark, which guarantees high quality and compliance with international standards. Novo Nordisk A/O is one of the world's leading insulin manufacturers and has extensive experience in the development and production of products for the management of diabetes mellitus.

When using Insulin Protafan, it is important to follow the individual dosage and doctor’s recommendations. The dose of insulin depends on several factors, including blood glucose levels, diet, physical activity, and the patient's general condition. Typically, Protafan insulin is injected subcutaneously once or twice a day.

Patients taking Insulin Protafan should be alert for hypoglycemia (low blood sugar). Signs of hypoglycemia may include dizziness, weakness, sweating, trembling, and increased sensitivity to hunger. If such symptoms occur, immediate measures must be taken to restore normal blood sugar levels